“Nationwide, 14% of law-school enrollees are pursuing non-J.D. programs, newly released numbers from the American Bar Association show,...

A brilliant new study on parachute use was recently published in the British Journal of Medicine. The researchers/authors presumably will...

Yes, there is medical malpractice as to genomic information. The first real study on the topic is from ASU’s Gary Marchant (PhD in...

Another step forward is happening in the effort to find lung cancers early.  It’s an early detection study – in the UK – using both...

It’s an interesting week for thinking about risk. As it happens, I’m presenting on lethal diseases and “real world evidence” at the...

The latest global failure of cyber security is covered in detail in a November 30, 2018 post at Krebs on Security, and is headline news...

A press release yesterday brought news of an interesting next step in the process of increasing the intersections between law and...

Over the years ahead, the term “somatic recombination” may make its way into the lexicon of more lawyers. Why? Because a new, high...

Age of exposure to toxins is receiving increasing attention from researchers. Below, the abstract from an interesting study of arsenic...

As the molecular revolution continues, take a look ahead to what trial lawyers will have for exhibits in the future: Watch Mouse Embryos...

Ever focused on science and law issues, Nathan Schactman’s October 3, 2018 post highlights several new articles focused on points of...

As pointed out in Tuesday’s post (September 18, 2018),  Praedicat and Allianz recently published facts and assessments on a “toxic” trio...

As pointed out in Tuesday’s post (September 18, 2018),  Praedicat and Allianz recently published facts and assessments on a “toxic” trio...

A few far sighted liability insurers are paying attention to molecular science as to alleged or actual toxins, often aided by the...

Use of genomic testing continues to increase to seek to explain the reasons for and drivers of cancer. Some aspects of the newest broad...

It’s good to see more lawyers focused on genomics as related to causation in mass tort cases. A group from Goldberg Segalla just wrote...

Some scientific findings provide both opportunities and risks for litigants in mass tort cases. The point is highlighted by a new paper...

For many years, astute observers  pointed out that “change” is the one constant in asbestos litigation. With that in mind, one might...

We continue to see increases in the the scale and pace of the development of molecular and genetic knowledge. A recent example arises...

For those interested in blockchain and CLE, an excellent, on demand program from The Center for Law, Science & Innovation at the ASU...